The impact of human allelic variation on HIV-1 disease

被引:26
作者
Anastassopoulou, CG [1 ]
Kostrikis, LG [1 ]
机构
[1] Univ Athens, Sch Med, Dept Hyg & Epidemiol, GR-11527 Athens, Goudi, Greece
关键词
polymorphisms; chemokines; real-time PCR; beacons; transmission; progression; allelic;
D O I
10.2174/1570162033485311
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human allelic variants influence the susceptibility to HIV-1 infection and/or the subsequent rates of disease progression towards AIDS that average ten years, although they vary greatly among infected subjects. In this respect, studies involving multiply exposed persons who remain uninfected, long-term nonprogressors (who remain asymptomatic for fifteen years or more) or, in contrast, rapid progressors (who develop AIDS within two to three years post-infection) as well as seroincident cohorts of patients with defined scroconversion dates have contributed to our comprehension of the effects of different natural human polymorphisms on HIV-1 disease. The current article aims at providing an up-to-date review on these polymorphisms that may be broadly classified into three general categories: (1) those that control viral entry into susceptible cells (namely, chemokine and chemokine receptor polymorphisms), (2) mutational variants of genes involved in immune regulation, such as interleukin-10 (IL-10), interleukin-4 (IL-4), tumor necrosis factor-alpha (TNF-alpha), and mannose-binding lectin (MBL), and (3) polymorphisms in genes involved in the adaptive immune recognition by T cells, [human leukocyte antigen (HLA) type]. Particular emphasis has been placed on the state-of-the-art biotechnological methodologies, such as "spectral genotyping" that utilizes molecular beacons in conjunction with polymerase chain reaction in real-time (real-time-PCR), which were developed to assist with the characterization of some of these determinants. Elucidating the functional role of these factors via the application of such biotechnological assays is expected to further enhance our understanding of the pathogenesis of HIV-1 infection, and, eventually, to enrich our therapeutic arsenal with novel antiviral agents or strategic approaches.
引用
收藏
页码:185 / 203
页数:19
相关论文
共 271 条
  • [11] Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1
    Bajetto, A
    Bonavia, R
    Barbero, S
    Piccioli, P
    Costa, A
    Florio, T
    Schettini, G
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 73 (06) : 2348 - 2357
  • [12] Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis
    Balotta, C
    Bagnarelli, P
    Corvasce, S
    Mazzucchelli, R
    Colombo, MC
    Papagno, L
    Santambrogio, S
    Ridolfo, AL
    Violin, M
    Berlusconi, A
    Velleca, R
    Facchi, G
    Moroni, M
    Clementi, M
    Galli, M
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02) : 285 - 289
  • [13] Homozygous Delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient
    Balotta, C
    Bagnarelli, P
    Violin, M
    Ridolfo, AL
    Zhou, D
    Berlusconi, A
    Corvasce, S
    Corbellino, M
    Clementi, M
    Clerici, M
    Moroni, M
    Galli, M
    [J]. AIDS, 1997, 11 (10) : F67 - F71
  • [14] A strong signature of balancing selection in the 5′ cis-regulatory region of CCR5
    Bamshad, MJ
    Mummidi, S
    Gonzalez, E
    Ahuja, SS
    Dunn, DM
    Watkins, WS
    Wooding, S
    Stone, AC
    Jorde, LB
    Weiss, RB
    Ahuja, SK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (16) : 10539 - 10544
  • [15] Contrasting frequencies of CCR5Δ32 and CCR2-64I alleles in the Tunisian population
    Barbouche, RM
    Hong, L
    Dellagi, K
    Kostrikis, LG
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (03) : 298 - 299
  • [16] Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5Δ32
    Benkirane, M
    Jin, DY
    Chun, RF
    Koup, RA
    Jeang, KT
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) : 30603 - 30606
  • [17] Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
    Berger, EA
    Murphy, PM
    Farber, JM
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 : 657 - 700
  • [18] A new classification for HIV-1
    Berger, EA
    Doms, RW
    Fenyö, EM
    Korber, BTM
    Littman, DR
    Moore, JP
    Sattentau, QJ
    Schuitemaker, H
    Sodroski, J
    Weiss, RA
    [J]. NATURE, 1998, 391 (6664) : 240 - 240
  • [19] Berger EA, 1997, AIDS, V11, pS3
  • [20] HIV-cell fusion - The viral mousetrap
    Binley, J
    Moore, JP
    [J]. NATURE, 1997, 387 (6631) : 346 - 348